CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Cherry Biotech is developing an organ-on-chip platform that mimics human multiorgan systems to replace animal testing in drug efficacy and toxicity studies. This innovative technology aims to improve preclinical research by providing a more accurate representation of human physiology.
To address the critical problem of the failure of animal testing to predict drug effects (toxicity and efficacy) in humans, Cherry Biotech develops a breakthrough organ-on-chip/MPS solution based on microfluidic technology.
Using human tissue, our IDEFIX technology mimics multiorgan physiology and physiopathology.
Our MPS platform aims to be the new standard as an alternative to animal experimentation in preclinical studies.
Indeed, our solution succeeds in tackling all major industry bottleneck…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
